Download Docs
Export

SPHINGOMYELIN SYNTHASE 2 (SMS2) DEFICIENCY ATTENUATES NFkB ACTIVATION, A POTENTIAL ANTI-ATHEROGENIC PROPERTY

61/46,240 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed April 18, 2008
Case Type Provisional
Status Provisional Application Expired
Child 12/426,324 Abandoned
Last Updated: 2 years, 5 months ago
Date # Transaction